MS (Gen Surgery), FRCS (Glas), FRCS (Edin.)

Senior Consultant Surgical Oncologist/Professor and Head of the Institution/Surgical Oncology -Sri Shankara Cancer Hospital & Research Centre.

Doctor's Message 

Languages spoken 

Kannada, English, Hindi, Telugu, Tamil, Malayalam, Urdu

Areas of Interest 

Academic Interests:
* Breast Cancer Treatment and Research
* Management of Gastrointestinal Tract Malignancies
* Head and Neck Cancers Management
* Cancer prevention
* Role of Nutrition in Cancer Care and Prevention
* Holistic Care of Patients including Yoga and Spirituality
* Patient Survivorship and Support
* Translational Research in Oncology
* Affordable Cancer Care Advocacy


1.Savitha Rajarajan, Aruna Korlimarla, Annie Alexander, C.E. Anupama, Rakesh , Ramesh, B.S. Srinath, T.S. Sridhar and Jyothi S. Prabhu Pre-Menopausal Women with Breast Cancers having high ER/PR Ratios in the context of higher circulating Testosterone tend to have poorer outcomes front, Endocrinal, 21.June.2021. https://doi.org/10.3389/fendo.2021.679756.

2. Nair MG, Prabhu JS, Korlimarla A, Rajarajan S. Hari P.S. Kaul R. Alexander A, Raghavan R, B.S. Srinath, Sridhar T.S, �miR-18a activates Wnt pathway in ER-Positive breast cancer and is associated with poor prognosis�. Cancer Med.2020;00:1-11. https://doi.org/10.1002/cam4.3183.

3.Krishna KL, Srinath B.S. Santosh D, Veluswamy S, Divyamala V, Sariya Mohammadi J, Kurupad V, Kulakarni S, Vaji P, Goud S, Dhanireddy S, Ram J.A. A comparative study of perioperative techniques to attain negative margins and spare healthy breast tissue in breast conserving surgery. Breast Dis.2020 Aug.17.doi:10.3233/BD-200443.E pub ahead of print.PMID: 32831188.

4.Annie Alexander, Rohini Kaluve, Jyothi S. Prabhu, Aruna Korlimala, BS Srinath, Suraj, Manjunath, Shekar Patil, K.S. Gopinath, TS Sridhar. The impact of Breast cancer on the patient and the family in Indian perspective. Indian J Palliat Care. 2019;25(1):66-72. doi:10.4103/IJPC.IJPC_158_18.

5.Krishna Desai, Radhika Aiyappa, Jyothi S prabhu, Madhumathy G Nair, Patrick Varun Lawrence, Aruna Korlimarla, Anupama CE, Annie Alexander, Rohini S kaluve, Suraj, Manjunath, Marjorrie Correa, BS Srinath, Shekar Patil, Anjali kalamdani, MSN Prasad and TS Sridhar: HR+HER2-breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells. Tumour biology: the journal of the International Society for Oncodevemopmental Biology and Medicine 39(3):1010428317695028. doi:10.1177/1010428317695028.